| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |